Location: Wuhu
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Wuhu
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W Phase 3 · Wannan Medical College Yijishan Hospital · Pfizer · NCT07028853 IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes NA · The First Affiliated Hospital of Wannan Medical College · Jinling Hospital, China · NCT06118840 Pleural Strain by Speckle-Tracking Ultrasound: Feasibility and Driving Pressure Associations Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT06911450 Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort Phase N/A · The First Affiliated Hospital of Shihezi University · First Affiliated Hospital of Wannan Medical College · NCT06963489 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi Phase 1 · The First Affiliated Hospital of Wannan Medical College · Shanghai Henlius Biotech · NCT07160335 The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer Phase N/A · Department of Urology, The First Affiliated Hospital of Wann · Anhui Provincial Hospital · NCT06737588 The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection in the Treatment of Acute Larg NA · The first affiliated hospital of Wannan Medical College · yilong Wang · NCT06374667 Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT07033260 Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS NA · The First Affiliated Hospital, Yijishan Hospital of Wannan M · First Affiliated Hospital of Wannan Medical College · NCT06143488 China HeadAche DIsorders RegiStry Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · Beijing Tiantan Hospital · NCT05334927 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo Phase 3 · The First Affiliated Hospital Of Wannan Medical College · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. Phase 3 · Wannan Medical College Yijishan Hospital · Pfizer · NCT06629779 Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis Phase 3 · The Second Affiliated Hospital of Wannan Medical College · Beijing InnoCare Pharma Tech Co., Ltd. · NCT06842199 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR Phase 3 · Wannan Medical College Yijishan Hospital · Eli Lilly and Company · NCT06119581 Safety and Efficacy of Ventricular Irrigation for Ventriculitis NA · The First Affiliated Hospital of Wannan Medical College · RenJi Hospital · NCT06358209 Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis Phase 2 · The Second Affiliated Hospital of Wannan Medical College · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07236099 ICP-332 in Subjects With Non-segmental Vitiligo Phase 2/Phase 3 · The First Affiliated Hospital of Wannan Medical College · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07047612 The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer Phase 2 · Wuhu Hospital Affiliated to East China Normal University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06452706 A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Phase 3 · The First Affiliated Hospital of Wannan Medical University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07043725 RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Smal Phase 3 · The First Affiliated Hospital of Wannan Medical College · RemeGen Co., Ltd. · NCT07416474 A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma Phase 3 · Research Site · AstraZeneca · NCT06471257 POASAC Study (Preoperative Anemia Severity and Classification Study) Phase N/A · Department of Anesthesiology, First Affiliated Hospital of W · Peking Union Medical College Hospital · NCT06499974 A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab Phase 3 · Research Site · AstraZeneca · NCT07520162 Focused Ultrasound Spleen Stimulation and Inflammation in Septic Shock NA · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT06990295 A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease Phase 3 · Yijishan Hospital of Wannan Medical College · Takeda · NCT05837897 Inferior Vena Cava Collapsibility Index and Intradialytic Hypotension Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT07033273 A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia Phase 3 · The First Affiliated Hospital of Wannan Medical College · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06900920 A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia Phase 3 · Investigator Site 03 · Waterstone Pharmaceutical (Wuhan) Co., LTD. · NCT07251309 ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis Phase 3 · The Second Affiliated Hospital of Wannan Medical College · Beijing InnoCare Pharma Tech Co., Ltd. · NCT06775860 Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT07022847
Look up another city
Look up another condition